NCT00488761View on ClinicalTrials.gov

Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2006

Study Completion Date

August 31, 2007

Conditions
Skin Diseases, Infectious
Interventions
DRUG

Tigecycline

Trial Locations (1)

Unknown

Multiple Cities

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00488761 - Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI | Biotech Hunter | Biotech Hunter